The MarketWatch News Department was not involved in the creation of this content.
Jun 09, 2020 (The Expresswire) --
The Global Recombinant DNA Technology Market will grow considerably in the coming years due to exceptional scientific advancements in gene therapy. According to a report by Fortune Business Insights, titled “Recombinant DNA Technology Market Size, Share and Global Trend By Product (Vaccines, Therapeutic Agents, Recombinant Protein, Others), By Component (Vectors, Expression System, Others), By Application (Diagnostics, Therapeutics, Food and Agriculture, Others), By End User (Biotechnology and Pharmaceutical Companies, Diagnostic Laboratories, Academic and Government Research Institutes, Other) and Geography Forecast till 2026,” the market will derive growth from the growing emphasis on research and development of recombinant DNA.
Browse Complete Report Details@https://www.fortunebusinessinsights.com/industry-reports/recombinant-dna-technology-market-101016
North America to Emerge as Leading Region; Strategic Collaborations are Key Growth Drivers
The report provides segmentation of the global recombinant NA technology market based on several aspects such as product, component type, application, end users, and regional demographics. Based on regional demographics, the report highlights some of the leading regions that have made their name heard in the global recombinant DNA technology market in recent years. Among all regions, Fortune Business Insights expects North America to emerge dominant in the coming years.
Growing investment in research and development of recombinant DNA technology, combined with increasing number of company collaborations will aid the growth of the recombinant DNA technology market in the coming years.
The recombinant DNA technology involves the process of combining molecules of two different species that are used to produce a new genetic combination. The applications of recombinant DNA technology across diversified domains have led to an increased global adoption across the world.
Key Segmentation of Recombinant DNA Technology Market:
- By Product
- Vaccines
- Therapeutic Agents
- Recombinant Protein
- By Component
- Vectors
- Expression System
- By Application
- Diagnostics
- Therapeutic
- Food and Agriculture
- By End User
- Biotechnology and Pharmaceutical Companies
- Diagnostic Laboratories
- Academic and Government Research Institutes
- Other
- By Geography
- North America (U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, and Rest of Latin America)
- Middle East and Africa (South Africa, GCC, and Rest of Middle East and Africa)
Some of the Main Key Players Covered in the Report
- Novartis AG
- Thermo Fisher Scientific Inc.
- Sanofi Pasteur Limited
- Merck KGaA, Genentech Inc.
- GlaxoSmithKline plc.
- Eli Lilly and Company
- Pfizer Inc.
- Janssen Pharmaceuticals Inc.
In addition to widespread applications, recent scientific advancements have contributed to the growing demand for recombinant DNA technology across the world. Backed by exceptional product advancements, recombinant DNA technology established dominance in the field of medicine and healthcare. The ability to develop radioactive probes has aided the recombinant DNA industry, owing to its ability to diagnose several diseases.
Besides healthcare, recombinant DNA finds applications in agriculture and farming. The recombinant DNA technology is being developed to produce genetically modified crops. The report highlights a few of the applications of the recombinant DNA technology and gauges the impact of these technologies on the global market.
Get PDF Brochure:https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/recombinant-dna-technology-market-101016
Backed by Successful Clinical Trials, Recombinant DNA Will Derive Several Usage Approvals
The exceptional properties possessed by recombinant DNA technology have led to a huge demand across the world. The growing demand for recombinant DNA technology is matched by the huge emphasis on the research and development of newer technologies. Growing emphasis on research and development has yielded several successful clinical trials, which in turn has brought about numerous usage approvals from regulatory authorities.
In August 2017, the United States Food and Drug Administration announced that it has passed approval for the ‘Kymriah’, a recombinant DNA technology aimed at the treatment of acute lymphoblastic leukemia in young as well as adult patients. The FDA went on to state that this would bee the first ever gene therapy treatment method which was approved in the United States.
Fortune Business Insights has predicted this was a major breakthrough in the recombinant DNA industry and states that this will be a step forward for the global recombinant DNA market. The report includes several usage approvals and gauges the impact of major activities on the growth of the global recombinant DNA technology market.
Fortune Business Insights profiles some of the leading companies that are operating in the global recombinant DNA technology market. A few of the prominent market companies include Novartis AG, Thermo Fisher Scientific Inc., Sanofi Pasteur Limited, Merck KGaA, Genentech Inc., GlaxoSmithKline plc., Eli Lilly and Company, Pfizer Inc., and Janssen Pharmaceuticals Inc.
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email:sales@fortunebusinessinsights.com
Press Release Distributed by The Express Wire
To view the original version on The Express Wire visit Recombinant DNA Technology Market Global Top Leading Player, Growth Insight, Competitive Analysis, Regional Trends, Share Forecast till 2026
COMTEX_366689427/2598/2020-06-09T02:33:13
Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.
The MarketWatch News Department was not involved in the creation of this content.
Gloss